Inside a big Q3: Venture capital for digital health is growing

Digital health funding remains strong so far this year, with $9.9 billion raised through Q3 and megarounds driving record deal sizes. However, the path to scale is becoming less predictable, as startups increasingly rely on unlabeled rounds and face longer timelines to reach Series B.

Editor's Pick

Top Story Inside a Big Q3: Venture Capital for Digital Health Continues to Grow Digital health funding remains strong so far this year, with $9.9 billion raised through Q3 and megarounds driving record deal sizes. However, the path to scale is becoming less predictable, as startups increasingly rely on unlabeled rounds and face longer timelines to reach Series B. Sponsored Critical Care Innovation Incubator – March 21, 2026, in Chicago Presented by Society of Critical Care Medicine Connect with top innovators and leaders advancing patient care. Submit your proposal by October 17 for a chance to win up to $10,000. Sponsorships are available to boost your brand's visibility. Don't miss your chance to shape the future of critical care—learn more and register today!

Featured News

The Future of AI in Healthcare Depends on Clinical Data Quality Assessment [Sponsored] Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be assessed and improved to build trust from the healthcare industry. CertifyOS Unveils Provider Data Platform to Streamline Operations and Cut Costs CertifyOS launched Provider Hub, an AI-powered platform that helps payers unify provider data and reduce administrative costs. Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug's potential to be combined with Novo Nordisk's Wegovy. Skye's drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1 receptors. The Tariff Opportunity for Medtech: Building the Supply Chain of the Future The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions.

Video   Beyond Traditional, Broken Health Models Daniel Karlin, chief medical officer of MindMed, spoke at DiMe's Healthcare 2030 Summit in Washington, D.C. His company is developing novel treatments for brain health disorders, with a focus on psychiatry, neurology and addiction. Karlin urged healthcare leaders to look beyond existing data and assumptions to create more meaningful, systemic improvements.

Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More.

Resources

MedCity FemFwd: How Evvy Is Advancing Women's Health Research In this episode, we're joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women's health research and what she hopes to achieve as a founding member of the Milken Institute's Women's Health Network. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe